✦ LIBER ✦

Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction

✍ Scribed by Gutstein, D E; Krishna, R; Johns, D; Surks, H K; Dansky, H M; Shah, S; Mitchel, Y B; Arena, J; Wagner, J A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A targeted dual therapy approach to card

✍ R.Preston Mason 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

A family approach to cardiovascular risk

✍ Theresa A. Nicklas; Marian L. Arbeit; Carolyn C. Johnson; Frank A. Franklin; Ger 📂 Article 📅 1987 🏛 Elsevier 🌐 English ⚖ 437 KB

0SOA02-5 A targeted dual therapy approac

✍ Mason, R.P. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Crystal structure of CETP: new hopes for

✍ Hamilton, James A; Deckelbaum, Richard J 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 603 KB

Measuring actual reduction of risk to ch

✍ George E. Fryer Jr.; Sherryll Kerns Kraizer; Thomas Mlyoshi 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 862 KB

A Novel Approach to Cardiovascular Healt

✍ Cox, Jafna L.; Vallis, T. Michael; Pfammatter, Angela; Szpilfogel, Claudine; Car 📂 Article 📅 2013 🏛 Pulsus Group Inc 🌐 English ⚖ 746 KB